Mimesis is a new Avicenna member!
We are truly delighted to welcome Mimesis as a new Avicenna member!
Mimesis is an innovative start-up, founded in 2020 as a spinoff of the University of Catania, which offers to the biomedical industry and pharmaceutical companies the first generation of in Silico solutions.
As part of the in Silico World project (HORIZON 2020), Mimesis is committed to reducing regulatory barriers in the adoption of in Silico models and is the result of more than twenty years of research by its partners.
More information about Mimesis can be found here